CVE-2017-11285

Description

Adobe ColdFusion has a cross-site scripting (XSS) vulnerability. This affects Update 4 and earlier versions for ColdFusion 2016, and Update 12 and earlier versions for ColdFusion 11.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 1.23% Top 25%
Vendor Advisory adobe.com
Affected: n/a Adobe ColdFusion Update 4 and earlier versions for ColdFusion 2016 release. Update 12 and earlier versions for ColdFusion 11.
Published at:
Updated at:

References

Link Tags
https://helpx.adobe.com/security/products/coldfusion/apsb17-30.html patch vendor advisory mitigation
http://www.securityfocus.com/bid/100711 vdb entry third party advisory
http://www.securitytracker.com/id/1039321 vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2017-11285?
CVE-2017-11285 has been scored as a medium severity vulnerability.
How to fix CVE-2017-11285?
To fix CVE-2017-11285, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-11285 being actively exploited in the wild?
It is possible that CVE-2017-11285 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-11285?
CVE-2017-11285 affects n/a Adobe ColdFusion Update 4 and earlier versions for ColdFusion 2016 release. Update 12 and earlier versions for ColdFusion 11..
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.